Abstract:Introduction: The human gut microbiome plays a pivotal role in health and disease, notably through its interaction with bile acids (BAs). BAs, synthesized in the liver, undergo transformation by the gut microbiota upon excretion into the intestine, thus influencing host metabolism. However, the potential mechanisms of dicaffeoylquinic acids (DiCQAs) from Ilex kudingcha how to modulate lipid metabolism and inflammation via gut microbiota remain unclear. Objectives and methods: The objectives of the present study were to investigate the regulating effects of DiCQAs on diabetes and the potential mechanisms of action. Two mice models were utilized to investigate the anti-diabetic effects of DiCQAs. Additionally, analysis of gut microbiota structure and functions was conducted concurrently with the examination of DiCQAs' impact on gut microbiota carrying the bile salt hydrolase (BSH) gene, as well as on the enterohepatic circulation of BAs and related signaling pathways. Results: Our findings demonstrated that DiCQAs alleviated diabetic symptoms by modulating gut microbiota carrying the BSH gene. This modulation enhanced intestinal barrier integrity, increased enterohepatic circulation of conjugated BAs, and inhibited the farnesoid X receptor-fibroblast growth factor 15 (FGF15) signaling axis in the ileum. Consequently, the protein expression of hepatic FGFR4 fibroblast growth factor receptor 4 (FGFR4) decreased, accompanied by heightened BA synthesis, reduced hepatic BA stasis, and lowered levels of hepatic and plasma cholesterol. Furthermore, DiCQAs upregulated glucolipid metabolism-related proteins in the liver and muscle, including v-akt murine thymoma viral oncogene homolog (AKT)/glycogen synthase kinase 3-beta (GSK3β) and AMP-activated protein kinase (AMPK), thereby ameliorating hyperglycemia and mitigating inflammation through the down-regulation of the MAPK signaling pathway in the diabetic group. Conclusion: Our study elucidated the anti-diabetic effects and mechanism of DiCQAs from I. kudingcha, highlighting the potential of targeting gut microbiota, particularly Acetatifactor sp011959105 and Acetatifactor muris carrying the BSH gene, as a therapeutic strategy to attenuate FXR-FGF15 signaling and ameliorate diabetes.

Inhibitory Activities of Ca ff eoylquinic Acid Derivatives from Ilex

Inhibitory Activities of Caffeoylquinic Acid Derivatives from Ilex Kudingcha C.J. Tseng on Α-Glucosidase from Saccharomyces Cerevisiae

Interaction Properties of Caffeoylquinic Acid Derivatives from Ilex kudingcha C. J. Tseng withα-Amylase

Compounds From Angelica Keiskei With Nqo1 Induction, Dpph Center Dot Scavenging And Alpha-Glucosidase Inhibitory Activities

Degradation, Isomerization and Stabilization of Three Dicaffeoylquinic Acids under Ultrasonic Treatment at Different Ph.

In Vitro Antioxidant Activity and Potential Inhibitory Action Against Α-Glucosidase of Polysaccharides from Fruit Peel of Tea (camellia Sinensis L.)

Quinic Acid As an Inhibitor of Α‐glucosidase Activity, Nonenzymatic Glycosylation, and Glucose Transport in Caco‐2 Cells

Inhibitory mechanism of xanthine oxidase activity by caffeoylquinic acids in vitro

Solvent Extraction of Caffeoylquinic Acids from Artemisia Selengensis Turcz Leaves and Their in Vitro Inhibitory Activities on Xanthine Oxidase

Modulating Effects of Dicaffeoylquinic Acids from Ilex Kudingcha on Intestinal Microecology in Vitro.

Caffeoylquinic acid derivatives isolated from the aerial parts of Gynura divaricata and their yeast α-glucosidase and PTP1B inhibitory activity

Three common caffeoylquinic acids as potential hypoglycemic nutraceuticals: Evaluation of α‐glucosidase inhibitory activity and glucose consumption in HepG2 cells

Screening and Characterization of an Α-Amylase Inhibitor from Carya Cathayensis Sarg. Peel

Isochlorogenic Acid A Affects P450 and UGT Enzymes in Vitro and in Vivo.

Caffeoyl Substitution Decreased the Binding and Inhibitory Activity of Quinic Acid Against Α-Amylase: the Reason Why Chlorogenic Acid is a Relatively Weak Enzyme Inhibitor

Interaction of bioactive components caffeoylquinic Acid derivatives in Chinese medicines with bovine serum albumin.

Advance in Dietary Polyphenols as α-Glucosidases Inhibitors: A Review on Structure-Activity Relationship Aspect

Dicaffeoylquinic Acids from Ilex Kudingcha Attenuate Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice in Association with the Modulation of Gut Microbiota

Hydrolysis of Dicaffeoylquinic Acids from Ilex kudingcha Happens in the Colon by Intestinal Microbiota

Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism

The inhibitory kinetics and mechanism of quercetin-3-O-rhamnoside and chlorogenic acid derived from Smilax china L. EtOAc fraction on xanthine oxidase